FDA Releases Rules to Shield Medical Devices from Cyber Threats
Published Date: 6/27/2025
Notice
Summary
The FDA just dropped new rules to make medical devices safer from hackers. If you make or sell these devices, you’ll need to follow updated steps for design, labeling, and paperwork to prove your device is secure. These changes kick in soon and could affect how much time and money you spend getting devices approved.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
New FDA Cybersecurity Submission Guidance
The FDA issued a final guidance titled "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" that updates the September 27, 2023 guidance and finalizes the March 13, 2024 draft. If you make or sell medical devices with cybersecurity risk, the guidance recommends what cybersecurity design, labeling, and documentation to include in premarket submissions and identifies information FDA considers necessary to meet obligations under the new amendments to the Federal Food, Drug, and Cosmetic Act (including Section 524B).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
Previous / Next Documents
Previous: 2025-10094, West Virginia Resource Advisory Committee
The West Virginia Resource Advisory Committee is meeting to talk about projects and funding for forests in five counties. They’ll also discuss recreation fees for spots in the Monongahela National Forest. If you live nearby or love these forests, this meeting could affect how your outdoor fun and local projects get funded and managed.
Next: 2025-11799, Environmental Impact Statements; Notice of Availability
The EPA just shared new Environmental Impact Statements (EIS) for projects like solar farms, nuclear plant renewals, and city redevelopments. If you’re involved in energy, manufacturing, or urban planning, now’s the time to check out these reports and share your thoughts before the deadlines in late July and early August. These reviews help protect the environment while supporting smart growth and energy choices.